Jim Cramer’s Game Plan: 15 Stocks to Watch

6. Abbott Laboratories (NYSE:ABT)

Number of Hedge Fund Holders: 66

As Abbott Laboratories (NYSE:ABT) is set to report on April 15, Cramer remarked:

“Wednesday morning, Robert Ford from Abbott Labs will tell his usual terrific story about the company’s strong franchises while having to mention the special baby formula lawsuits that have hurt the stock’s valuation for such a long time. It was 14 points higher not that long ago during that ridiculous rotation where I told you I had to sell some. These stocks are now all the way back down. That rotation was horrendous and I’ll still like to find out what firms did that because they should be kept away from anybody’s money.”

Abbott Laboratories (NYSE:ABT) is a healthcare company involved in researching, developing, producing, and promoting a broad range of medical products. On March 14, during an episode of Squawk on the Street, Cramer said:

“Now I do wanna point out a stock that we’ve been selling for the Charitable Trust, Abbott Labs. There’s a lawsuit that’s been overturned, we talked about that when Robert Ford was on last time. About a very particular kind of specialized infant baby food. A shocking overturning and I’m getting ready to wanna buy the stock back.”